scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1046470440 |
P356 | DOI | 10.1007/S00439-012-1235-6 |
P8608 | Fatcat ID | release_oml7mx5vavanneykccs7svl6tq |
P3181 | OpenCitations bibliographic resource ID | 4648152 |
P932 | PMC publication ID | 3543766 |
P698 | PubMed publication ID | 23052947 |
P5875 | ResearchGate publication ID | 232229642 |
P50 | author | Karl Skorecki | Q28468792 |
P2093 | author name string | Harry Ostrer | |
P2860 | cites work | Counting the founders: the matrilineal genetic ancestry of the Jewish Diaspora | Q21092214 |
Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women | Q21145218 | ||
Genomic microsatellites identify shared Jewish ancestry intermediate between Middle Eastern and European populations | Q21283811 | ||
Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection | Q24532103 | ||
A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases | Q24534086 | ||
The Y chromosome pool of Jews as part of the genetic landscape of the Middle East | Q24536155 | ||
Distinctive genetic signatures in the Libyan Jews | Q24544776 | ||
Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: a call for dialogue | Q84237419 | ||
Changing the game with whole exome sequencing | Q84545729 | ||
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population | Q24606497 | ||
North African Jewish and non-Jewish populations form distinctive, orthogonal clusters | Q24612939 | ||
Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry | Q24632067 | ||
Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations | Q24634589 | ||
Y-chromosomal diversity in Lebanon is structured by recent historical events | Q24655527 | ||
Genetic affinities of Jewish populations | Q24678482 | ||
Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes | Q24683595 | ||
The genetic legacy of Paleolithic Homo sapiens sapiens in extant Europeans: a Y chromosome perspective | Q28143588 | ||
Screening and prevention in Tay-Sachs disease: origins, update, and impact | Q28155734 | ||
Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations | Q28240347 | ||
The genome-wide structure of the Jewish people | Q28284600 | ||
Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population | Q28943392 | ||
Identification of population substructure among Jews using STR markers and dependence on reference populations included | Q33603693 | ||
The impact of Converso Jews on the genomes of modern Latin Americans | Q34203492 | ||
Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa | Q34267725 | ||
Y chromosome evidence for a founder effect in Ashkenazi Jews | Q34364737 | ||
Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population | Q34574542 | ||
Analysis of biochemical genetic data on Jewish populations: II. Results and interpretations of heterogeneity indices and distance measures with respect to standards | Q35203176 | ||
Population genetic studies in the Congo. I. Glucose-6-phosphate dehydrogenase deficiency, hemoglobin S, and malaria | Q35231411 | ||
ETHNOS : A versatile electronic tool for the development and curation of national genetic databases | Q36405286 | ||
Clinical practice. Management of an inherited predisposition to breast cancer | Q36877519 | ||
Ethnic communities in Israel: the genetic blood markers of the Moroccan Jews | Q38914471 | ||
Genetic markers in Libyan Jews | Q38914478 | ||
Jewish populations of the world: genetic likeness and differences | Q39142711 | ||
Various genetic traits and diseases among the Jewish ethnic groups | Q40907082 | ||
The genetic origin of the Jews: a multivariate approach | Q41448626 | ||
Ethnic distribution of disease in non-Jews | Q44500823 | ||
Stage II follow-up on a linkage scan for bipolar disorder in the Ashkenazim provides suggestive evidence for chromosome 12p and the GRIN2B gene | Q46897329 | ||
A genetic profile of contemporary Jewish populations | Q47596505 | ||
Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation | Q48784105 | ||
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% | Q57250766 | ||
Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands | Q59548851 | ||
20. Screening and prevention in Tay-Sachs disease: Origins, update, and impact | Q60962642 | ||
Ethnic communities in Israel: the genetic blood markers of the Babylonian Jews | Q67434390 | ||
Enzyme replacement therapy for Gaucher disease | Q82871166 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Jewish people | Q7325 |
population genetics | Q31151 | ||
P304 | page(s) | 119-27 | |
P577 | publication date | 2013-02-01 | |
P1433 | published in | Human Genetics | Q5937167 |
P1476 | title | The population genetics of the Jewish people | |
P478 | volume | 132 |
Q40667799 | A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF. |
Q57161637 | A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population |
Q47586511 | Ashkenazi Jewish genomic variants: integrating data from the Israeli National Genetic Database and gnomAD. |
Q36717412 | CHRNA5/A3/B4 Variant rs3743078 and Nicotine-Related Phenotypes: Indirect Effects Through Nicotine Craving |
Q42690589 | Consanguinity Rates Predict Long Runs of Homozygosity in Jewish Populations. |
Q34390149 | Demographic histories, isolation and social factors as determinants of the genetic structure of Alpine linguistic groups. |
Q35477725 | Echoes from Sepharad: signatures on the maternal gene pool of crypto-Jewish descendants |
Q90471705 | Epidemiology of DYT1 dystonia: Estimating prevalence via genetic ascertainment |
Q40044373 | Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study. |
Q36746589 | Expanded genetic screening panel for the Ashkenazi Jewish population. |
Q61639626 | Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations |
Q33882519 | Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma |
Q40710686 | Genome-wide association study of schizophrenia in Ashkenazi Jews. |
Q53787657 | High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina. |
Q92528008 | High-resolution inference of genetic relationships among Jewish populations |
Q57472931 | In the blood: the myth and reality of genetic markers of identity |
Q55027605 | Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population. |
Q53077196 | Israeli-born offspring of Jewish immigrants of Middle Eastern origin have a lower incidence of multiple myeloma than those of European origin: a cohort study of 746 200 Israeli men followed from late adolescence. |
Q92274281 | Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients |
Q39578184 | Light and the City: Breast Cancer Risk Factors Differ Between Urban and Rural Women in Israel |
Q27301832 | Localizing Ashkenazic Jews to Primeval Villages in the Ancient Iranian Lands of Ashkenaz. |
Q104135110 | Middle eastern genetic legacy in the paternal and maternal gene pools of Chuetas |
Q59664869 | Molecular Historiography – neue Gegenstände und neue Methoden einer neuen Geschichtsschreibung? |
Q26824838 | Personalized medicine and human genetic diversity |
Q34458720 | Pharmacogenetics in Jewish populations. |
Q56536343 | Population Genetics of the Ashkenazim |
Q90110283 | Population Histories of the United States Revealed through Fine-Scale Migration and Haplotype Analysis |
Q28085453 | Portuguese crypto-Jews: the genetic heritage of a complex history |
Q59566816 | Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum |
Q39453354 | Risk of Hodgkin lymphoma according to immigration status and origin: a migrant cohort study of 2.3 million Jewish Israelis |
Q34184913 | Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins |
Q34519640 | The Genetics of Bene Israel from India Reveals Both Substantial Jewish and Indian Ancestry |
Q57474160 | The Origin of Ashkenazi Jewry: The Controversy Unraveled |
Q37250474 | The genetic history of Cochin Jews from India |
Q41578639 | Trends in human papillomavirus-related oropharyngeal cancer in Israel |
Q42373278 | Was ADH1B under Selection in European Populations? |
Q37187461 | Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease |
Q47260540 | Whole-exome sequencing reveals POC5 as a novel gene associated with autosomal recessive retinitis pigmentosa |
Search more.